Stock Scorecard

Stock Summary for NeuroOne Medical Technologies Corp (NMTC) - $0.58 as of 4/18/2025 7:42:36 AM EST

Total Score

10 out of 30

Safety Score

18 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NMTC

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NMTC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NMTC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for NMTC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for NMTC (18 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 2
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 8
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for NMTC

NeuroOne® OneRF® Technology Success Story Featured on Fox News 4/14/2025 1:00:00 PM
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet - NeuroOne Medical Tech ( NASDAQ:NMTC ) , Nabors Industries ( NYSE:NBR ) 4/4/2025 4:57:00 PM
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March - AIM ImmunoTech ( AMEX:AIM ) , Impact BioMedical ( AMEX:IBO ) 4/4/2025 1:53:00 PM
NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock 4/4/2025 12:30:00 PM
US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert - Apple ( NASDAQ:AAPL ) , American Shared Hospital ( AMEX:AMS ) 4/4/2025 10:18:00 AM
Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert - Apple ( NASDAQ:AAPL ) , American Shared Hospital ( AMEX:AMS ) 4/4/2025 10:18:00 AM
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday - Guess ( NYSE:GES ) , American Shared Hospital ( AMEX:AMS ) 4/4/2025 7:02:00 AM
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update 3/18/2025 5:12:00 PM
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - NeuroOne Medical Tech ( NASDAQ:NMTC ) 3/18/2025 12:46:00 PM
Neurosurgery Market Size to Reach USD 6.8 Billion by 2034, Growing at 4.5% CAGR with Technological Advancements and Rising Focus on Personalized Medicine - Analysis by TMR 3/12/2025 2:02:00 PM

Financial Details for NMTC

Company Overview
Ticker NMTC
Company Name NeuroOne Medical Technologies Corp
Country USA
Description NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.
Sector Name REAL ESTATE & CONSTRUCTION
Industry Name PATENT OWNERS & LESSORS
Most Recent Quarter 12/31/2024
Next Earnings Date 5/12/2025

Stock Price History
Last Day Price 0.58
Price 4 Years Ago 1.94
Last Day Price Updated 4/18/2025 7:42:36 AM EST
Last Day Volume 493,195
Average Daily Volume 320,211
52-Week High 1.39
52-Week Low 0.40
Last Price to 52 Week Low 45.00%

Valuation Measures
Trailing PE N/A
Industry PE 16.94
Sector PE 67.71
5-Year Average PE 1.05
Free Cash Flow Ratio 29.00
Industry Free Cash Flow Ratio 9.66
Sector Free Cash Flow Ratio 86.00
Current Ratio Most Recent Quarter 3.64
Total Cash Per Share 0.02
Book Value Per Share Most Recent Quarter 0.10
Price to Book Ratio 8.72
Industry Price to Book Ratio 3.33
Sector Price to Book Ratio 12.61
Price to Sales Ratio Twelve Trailing Months 4.65
Industry Price to Sales Ratio Twelve Trailing Months 5.97
Sector Price to Sales Ratio Twelve Trailing Months 4.09
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 47,385,500
Market Capitalization 27,483,590
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -3.87%
Reported EPS 12 Trailing Months -0.26
Reported EPS Past Year 0.06
Reported EPS Prior Year -0.46
Net Income Twelve Trailing Months -7,187,888
Net Income Past Year -12,318,110
Net Income Prior Year -11,859,491
Quarterly Revenue Growth YOY 234.90%
5-Year Revenue Growth 613.83%
Operating Margin Twelve Trailing Months 52.30%

Balance Sheet
Total Cash Most Recent Quarter 1,134,350
Total Cash Past Year 1,460,042
Total Cash Prior Year 5,322,493
Net Cash Position Most Recent Quarter 1,134,350
Net Cash Position Past Year 1,460,042
Long Term Debt Past Year 0
Long Term Debt Prior Year 1,007,206
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 822,013
Total Stockholder Equity Prior Year 6,249,404
Total Stockholder Equity Most Recent Quarter 2,935,292

Free Cash Flow
Free Cash Flow Twelve Trailing Months -7,101,882
Free Cash Flow Per Share Twelve Trailing Months -0.15
Free Cash Flow Past Year -11,132,037
Free Cash Flow Prior Year -13,270,991

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.13
MACD Signal -0.13
20-Day Bollinger Lower Band 0.45
20-Day Bollinger Middle Band 0.92
20-Day Bollinger Upper Band 1.39
Beta 0.69
RSI 37.05
50-Day SMA 0.90
150-Day SMA 1.20
200-Day SMA 1.64

System
Modified 4/17/2025 7:11:26 AM EST